Medical Xpress·3 min read·hard
Blood gene test detects 90% of early-stage pancreatic cancers
K
Kanazawa University
✦AI Summary
Researchers at Kanazawa University have developed a blood-based gene expression test that can detect early-stage pancreatic cancer. This non-invasive method aims to improve survival rates by identifying the disease when it is still surgically treatable.
Why it matters
Pancreatic cancer has a notoriously low survival rate due to late detection; this technology could significantly improve patient outcomes.
edited by Gaby Clark , reviewed by Andrew Zinin
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The article reports on scientific research findings without political or social bias.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in